George Lagoumintzis

Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions

Nikolaos Alexandris, George Lagoumintzis, Christos T. Chasapis et al. · Toxicology Reports · 2020 · 71 citations · Full text

Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins

George Lagoumintzis, Christos T. Chasapis, Nikolaos Alexandris et al. · Food and Chemical Toxicology · 2021 · 52 citations · Full text

Medicine, Nicotine, Immunology +7

A Critical View of the General Public‘s Awareness and Physicians‘ Opinion of the Trends and Potential Pitfalls of Genetic Testing in Greece

Yuan Mai, Theodora Koromila, Aggeliki Sagia et al. · Personalized Medicine · 2011 · 50 citations

Transcutaneous delivery of a nanoencapsulated antigen: Induction of immune responses

George Mattheolabakis, George Lagoumintzis, Z. Panagi et al. · International Journal of Pharmaceutics · 2009 · 49 citations

Nanoparticles, Nanomedicine, Cross-protection +11

Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients

Gregory Kordas, George Lagoumintzis, Sotirios Sideris et al. · PLoS ONE · 2014 · 49 citations · Full text

Disease Etiology, Immunology, Pathology +25